🇺🇸 FDA
Patent

US 12419955

Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus

granted A61KA61K2239/11A61K40/11

Quick answer

US patent 12419955 (Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus) held by Beijing Gene MINK Biotechnology CO.LTD expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beijing Gene MINK Biotechnology CO.LTD
Grant date
Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2239/11, A61K40/11, A61K40/15, A61K40/31